| Literature DB >> 17436113 |
Martin P Paulus1, Murray B Stein.
Abstract
In this review, we survey the state of the field of functional magnetic resonance imaging (fMRI) as it relates to drug discovery and drug development. We highlight the advantages and limitations of fMRI for this purpose and suggest ways to improve the use of fMRI for developing new therapeutics, with emphasis on treatments for anxiety disorders. Fundamentally, pharmacological studies with standard psychiatric treatments using standardized behavioral probes during fMRI will need to be carried out to determine characteristic brain signatures that could be used to predict whether novel compounds are likely to have specific therapeutic effects.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17436113 PMCID: PMC2841045 DOI: 10.1007/s11065-007-9023-0
Source DB: PubMed Journal: Neuropsychol Rev ISSN: 1040-7308 Impact factor: 7.444